Assessment of Angiographic Vascularity of Meningiomas with Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted Imaging and Diffusion Tensor Imaging

References

1. 1.↵
   1. Wiemels J,
   2. Wrensch M,
   3. Claus EB

   . Epidemiology and etiology of meningioma. J Neurooncol 2010;99:307–14

   CrossRefPubMed
2. 2.↵
   1. Willinsky RA,
   2. Taylor SM,
   3. TerBrugge K,
   4. et al

   . Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 2003;227:522–28

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Sasao A,
   2. Hirai T,
   3. Nishimura S,
   4. et al

   . Assessment of vascular supply of hypervascular extra-axial brain tumors with 3T MR regional perfusion imaging. AJNR Am J Neuroradiol 2010;31:554–58

   Abstract/FREE Full Text
4. 4.↵
   1. Uetani H,
   2. Akter M,
   3. Hirai T,
   4. et al

   . Can 3T MR angiography replace DSA for the identification of arteries feeding intracranial meningiomas? AJNR Am J Neuroradiol 2013;34:765–72

   Abstract/FREE Full Text
5. 5.↵
   1. Mukherjee P,
   2. Berman JI,
   3. Chung SW,
   4. et al

   . Diffusion tensor MR imaging and fiber tractography: theoretic underpinnings. AJNR Am J Neuroradiol 2008;29:632–41

   Abstract/FREE Full Text
6. 6.↵
   1. Zaharchuk G

   . Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability. AJNR Am J Neuroradiol 2007;28:1850–58

   Abstract/FREE Full Text
7. 7.↵
   1. Toh CH,
   2. Castillo M,
   3. Wong AM,
   4. et al

   . Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging. AJNR Am J Neuroradiol 2008;29:1630–35

   Abstract/FREE Full Text
8. 8.↵
   1. Wang S,
   2. Kim S,
   3. Zhang Y,
   4. et al

   . Determination of grade and subtype of meningiomas by using histogram analysis of diffusion-tensor imaging metrics. Radiology 2012;262:584–92

   CrossRefPubMed
9. 9.↵
   1. Zhang H,
   2. Rodiger LA,
   3. Shen T,
   4. et al

   . Preoperative subtyping of meningiomas by perfusion MR imaging. Neuroradiology 2008;50:835–40

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Zhang H,
    2. Rodiger LA,
    3. Shen T,
    4. et al

    . Perfusion MR imaging for differentiation of benign and malignant meningiomas. Neuroradiology 2008;50:525–30

    CrossRefPubMed
11. 11.↵
    1. Kimura H,
    2. Takeuchi H,
    3. Koshimoto Y,
    4. et al

    . Perfusion imaging of meningioma by using continuous arterial spin-labeling: comparison with dynamic susceptibility-weighted contrast-enhanced MR images and histopathologic features. AJNR Am J Neuroradiol 2006;27:85–93

    Abstract/FREE Full Text
12. 12.↵
    1. Toh CH,
    2. Wei KC,
    3. Ng SH,
    4. et al

    . Differentiation of brain abscesses from necrotic glioblastomas and cystic metastatic brain tumors with diffusion tensor imaging. AJNR Am J Neuroradiol 2011;32:1646–51

    Abstract/FREE Full Text
13. 13.↵
    1. Toh CH,
    2. Wei KC,
    3. Ng SH,
    4. et al

    . Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging. AJNR Am J Neuroradiol 2012;33:846–51

    Abstract/FREE Full Text
14. 14.↵
    1. Boxerman JL,
    2. Schmainda KM,
    3. Weisskoff RM

    . Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67

    Abstract/FREE Full Text
15. 15.↵
    1. Toh CH,
    2. Wei KC,
    3. Chang CN,
    4. et al

    . Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. AJNR Am J Neuroradiol 2013;34:1145–49

    Abstract/FREE Full Text
16. 16.↵
    1. Sluzewski M,
    2. van Rooij WJ,
    3. Lohle PN,
    4. et al

    . Embolization of meningiomas: comparison of safety between calibrated microspheres and polyvinyl-alcohol particles as embolic agents. AJNR Am J Neuroradiol 2013;34:727–29

    Abstract/FREE Full Text
17. 17.↵
    1. Shah AH,
    2. Patel N,
    3. Raper DM,
    4. et al

    . The role of preoperative embolization for intracranial meningiomas. J Neurosurg 2013;119:364–72

    CrossRefPubMed
18. 18.↵
    1. Borg A,
    2. Ekanayake J,
    3. Mair R,
    4. et al

    . Preoperative particle and glue embolization of meningiomas: indications, results and lessons learned from 117 consecutive patients. Neurosurgery 2013 Feb 25 [Epub ahead of print]
19. 19.↵
    1. Hu LS,
    2. Eschbacher JM,
    3. Dueck AC,
    4. et al

    . Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. AJNR Am J Neuroradiol 2012;33:69–76

    Abstract/FREE Full Text
20. 20.↵
    1. Liao W,
    2. Liu Y,
    3. Wang X,
    4. et al

    . Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009;50:217–25

    Abstract/FREE Full Text
21. 21.↵
    1. Sadeghi N,
    2. D'Haene N,
    3. Decaestecker C,
    4. et al

    . Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476–82

    Abstract/FREE Full Text
22. 22.↵
    1. Barajas RF Jr.,
    2. Phillips JJ,
    3. Parvataneni R,
    4. et al

    . Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR imaging. Neuro Oncol 2012;14:942–54

    Abstract/FREE Full Text
23. 23.↵
    1. Maia AC Jr.,
    2. Malheiros SM,
    3. da Rocha AJ,
    4. et al

    . MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol 2005;26:777–83

    Abstract/FREE Full Text
24. 24.↵
    1. Bitzer M,
    2. Opitz H,
    3. Popp J,
    4. et al

    . Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir (Wien) 1998;140:333–40

    CrossRefPubMed
25. 25.↵
    1. Ginat DT,
    2. Mangla R,
    3. Yeaney G,
    4. et al

    . Correlation between dynamic contrast-enhanced perfusion MRI relative cerebral blood volume and vascular endothelial growth factor expression in meningiomas. Acad Radiol 2012;19:986–90

    CrossRefPubMed
26. 26.↵
    1. Sugahara T,
    2. Korogi Y,
    3. Kochi M,
    4. et al

    . Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479–86

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Tropine A,
    2. Dellani PD,
    3. Glaser M,
    4. et al

    . Differentiation of fibroblastic meningiomas from other benign subtypes using diffusion tensor imaging. J Magn Reson Imaging 2007;25:703–08

    CrossRefPubMed
28. 28.↵
    1. Le Bihan D,
    2. Breton E,
    3. Lallemand D,
    4. et al

    . MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–07

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Koh DM,
    2. Collins DJ,
    3. Orton MR

    . Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 2011;196:1351–61

    CrossRefPubMed
30. 30.↵
    1. Chavarria L,
    2. Alonso J,
    3. Garcia-Martinez R,
    4. et al

    . Biexponential analysis of diffusion-tensor imaging of the brain in patients with cirrhosis before and after liver transplantation. AJNR Am J Neuroradiol 2011;32:1510–17

    Abstract/FREE Full Text